Quent Capital’s Health Catalyst HCAT Stock Holding History

Quent Capital’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,000	Closed	-$91K	–	1335
2023 Q1	$91K	Hold	8,000	–	–	0.02%	435
2022 Q4	$85K	Hold	8,000	–	–	0.02%	444
2022 Q3	$78K	Hold	8,000	–	–	0.02%	428
2022 Q2	$116K	Hold	8,000	–	–	0.02%	321
2022 Q1	$209K	Hold	8,000	–	–	0.04%	267
2021 Q4	$317K	Buy	+8,000	New	+$365K	0.07%	209

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Daventry Group New York $133M AUM 32.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Quent Capital's HCAT Position: Q2 2023 in Review

Quent Capital sold out of Health Catalyst (HCAT) in Q2 2023, closing a stake of 8,000 shares — an estimated $91K sold.

Quent Capital first reported a position in HCAT in Q4 2021 and held it in 6 quarters. The position peaked at $317K in Q4 2021. 154 funds tracked by Wall St. Rank hold HCAT as of Q2 2023.

Quent Capital reported no remaining Health Catalyst position as of Q2 2023 after selling out during the quarter.
Quent Capital sold 8,000 Health Catalyst shares in Q2 2023, an estimated $91K.
Quent Capital first reported a position in Health Catalyst in Q4 2021 and held it in 6 quarters.
Quent Capital's Health Catalyst position peaked at $317K in Q4 2021.
154 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2023.

Based on Quent Capital's 13F filing for Q2 2023, filed 10 Jul 2023.